Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial Newly diagnosed patients enrolled on the COG ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback